miRagen Therapeutics to Participate in Two Investor Conferences in May
Apr 26, 2017 11:01 am UTC| Business
BOULDER, Colo., April 26, 2017 -- Miragen Therapeutics, Inc. (Nasdaq:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA-targeted therapies, today announced that...
MacroGenics to Present at Two Upcoming Investor Conferences in May
Apr 26, 2017 11:01 am UTC| Business
Rockville, MD, April 26, 2017 -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the...
MacroGenics to Present at Two Upcoming Investor Conferences in May
Apr 26, 2017 11:01 am UTC| Business
Rockville, MD, April 26, 2017 -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the...
Hershey Announces First-Quarter Results; Updates 2017 Outlook
Apr 26, 2017 11:00 am UTC| Business
• First-quarter net sales increased 2.8% including the impact of acquisitions and foreign currency exchange rates Acquisitions and foreign currency exchange rates a 0.9 point and 0.1 point benefit, respectively ...
Apr 26, 2017 11:00 am UTC| Business
MALVERN, Penn., April 26, 2017 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led, biotechnology company focused on defining innovative therapies in medical and aesthetic dermatology, today announced that...
Apr 26, 2017 11:00 am UTC| Business
WALL TOWNSHIP, N.J., April 26, 2017 -- Coates International, Ltd. (OTC PINK:COTE) (the “Company”) is pleased to announce that our projects are moving forward. The first industrial V12 QST 30-G4 engine for the hydrogen...
Apr 26, 2017 11:00 am UTC| Business
OKLAHOMA CITY, April 26, 2017 -- Gulfport Energy Corporation (NASDAQ:GPOR) (“Gulfport” or the “Company”) today scheduled its first quarter 2017 financial and operational results conference call. Gulfport will hold a...